Titre:
  • Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial
Auteur:Tombal, Bertrand; Choudhury, Ananya; Saad, Fred; Gallardo, Enrique; Soares, Andrey; Loriot, Yohann; McDermott, Ray; Rodriguez-Vida, Alejo; Velho, Pedro Isaacsson; Nolè, Franco; Cruz, Felipe; Roumeguere, Thierry; Daugaard, Gedske; Yamamura, Rosely; Bompas, Emmanuelle; Maroto, Pablo; Gómez Veiga, Francisco; Skoneczna, Iwona; Martins da Trindade, Karine; Mavignier Carcano, F.; Lecouvet, Frédéric; Coens, Corneel; Poncet, Coralie; Fournier, Beatrice; Gillessen, Silke
Informations sur la publication:Annals of oncology
Statut de publication:Publié, 2025
Sujet CREF:Cancérologie
Hématologie
Mots-clés:bone metastases
enzalutamide
metastatic castration-resistant prostate cancer
radium-223
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1016/j.annonc.2025.05.011
info:pii/S0923753425002030
info:scp/105006947485